Cellectis, Genoway Reach Agreement on Terminated License | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Cellectis and Genoway said that they have reached an agreement on how to handle orders of products covered by a licensing agreement between the firms that was terminated in late 2008.

In December 2008, Cellectis terminated a non-exclusive license that granted Genoway access to patents covering certain uses of homologous recombination. The initial license had been signed in 2001.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Pacific Biosciences is hosting a competition in which researchers are vying to win free sequencing for an organism with the most interesting genome.

An opinion piece appearing in Newsday likens familial DNA searches to stop-and-frisk policies.

The San people of Africa have drawn up a code of conduct for researchers, according to the Conversation.

In Nature this week: genotypes linked to hip osteoarthritis, and more.